Skip to main content
. 2019 May 8;20(9):2272. doi: 10.3390/ijms20092272
αSMA Alpha Smooth Muscle Actin
BMDCs Bone Marrow Derived Cells
CAF Cancer Associated Fibroblast
CCL2 Chemokine (C-C motif) Ligand 2
CCL21 Chemokine (C-C motif) Ligand 21
CCR7 Chemokine (C-C motif) Receptor Type 7
COX2 Cyclooxygenase-2
CSF-1 Colony Stimulating Factor 1
CTC Circulating Tumor Cell
CXCR4 Chemokine (C-X motif) receptor 4
ECM Extracellular Matrix
EGFR Epidermal Growth Factor Receptor
EMT Epithelial to Mesenchymal Transition
G-CSF Granulocyte-Colony Stimulating Factor
HIF-1α Hypoxia Inducible Factor-1 Alpha
HPCs Hematopoietic Progenitor Cells
IL-6/32 Interleukin–6 or 32
LOX Lysyl Oxidase
LOXL Lysyl Oxidase-Like
Ly6C Lymphocyte Antigen 6 Complex
p38 MAPK p38 Mitogen-Activated Protein Kinase
MDSCs Myeloid Derived Suppressor Cells
MET Mesenchymal-Epithelial Transition
MIP2 Macrophage Inflammatory Protein–2
MMP2/9 Matrix Metalloproteinase 2 or 9
NF-κB Nuclear Factor Kappa-light-chain-enhancer of activated B cells
PDGFR-β Platelet Derived Growth Factor Receptor Beta
PD-L1 Programmed Cell Death Ligand 1
PGE2 Prostaglandin E2
SDF-1 Stromal Derived Factor 1
S100A8/9 S100 Calcium Binding Protein A8/9
Src-FAK Steroid Receptor Co-activator-Focal Adhesion Kinase
TDSFs Tumor Derived Soluble Factors
TDEs Tumor Derived Exosomes
TGFβ Transforming Growth Factor Beta
TNFα Tumor Necrosis Factor Alpha
VEGFR-1 Vascular Endothelial Growth Factor Receptor-1
VLA-4 Very Late Antigen-4
ZO-1 Zonula Occludens-1